Resistance training as supportive measure in advanced cancer patients undergoing TKI therapy: a controlled feasibility trial

Purpose: While there is growing evidence for positive effects of progressive resistance training in curatively treated cancer patients, data on advanced cancer patients are scarce. This pilot study aimed at investigating for the first time feasibility and effects of progressive resistance training i...

Full description

Saved in:
Bibliographic Details
Main Authors: Rosenberger, Friederike (Author) , Wiskemann, Joachim (Author) , Vallet, Sonia (Author) , Haag, Georg Martin (Author) , Schembri, Emanuel (Author) , Jäger, Dirk (Author) , Grüllich, Carsten (Author)
Format: Article (Journal)
Language:English
Published: December 2017
In: Supportive care in cancer
Year: 2017, Volume: 25, Issue: 12, Pages: 3655-3664
ISSN:1433-7339
DOI:10.1007/s00520-017-3788-3
Online Access:Verlag, Volltext: http://dx.doi.org/10.1007/s00520-017-3788-3
Verlag, Volltext: https://link.springer.com/article/10.1007/s00520-017-3788-3
Get full text
Author Notes:F. Rosenberger, J. Wiskemann, S. Vallet, G. M. Haag, E. Schembri, D. Jäger, C. Grüllich

MARC

LEADER 00000caa a2200000 c 4500
001 1572128313
003 DE-627
005 20220814115711.0
007 cr uuu---uuuuu
008 180418s2017 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00520-017-3788-3  |2 doi 
035 |a (DE-627)1572128313 
035 |a (DE-576)502128313 
035 |a (DE-599)BSZ502128313 
035 |a (OCoLC)1341007172 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rosenberger, Friederike  |e VerfasserIn  |0 (DE-588)137399057  |0 (DE-627)592612139  |0 (DE-576)30354354X  |4 aut 
245 1 0 |a Resistance training as supportive measure in advanced cancer patients undergoing TKI therapy  |b a controlled feasibility trial  |c F. Rosenberger, J. Wiskemann, S. Vallet, G. M. Haag, E. Schembri, D. Jäger, C. Grüllich 
264 1 |c December 2017 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 18.04.2018 
520 |a Purpose: While there is growing evidence for positive effects of progressive resistance training in curatively treated cancer patients, data on advanced cancer patients are scarce. This pilot study aimed at investigating for the first time feasibility and effects of progressive resistance training in advanced cancer patients undergoing tyrosine kinase inhibitor (TKI) therapy.MethodsPatients starting a TKI-based anti-tumor therapy were assigned to a resistance training group (RT, 12 weeks of progressive machine-based resistance training 2×/week) or a control group (CON, treatment as usual) until 10 patients had finished in each group (RT 80% males, 90% renal cell carcinoma, 65 ± 11 years, CON 80% males, 70% renal cell carcinoma, 61 ± 6 years). Primary endpoint was feasibility. Furthermore, fatigue (MFI), quality of life (QoL, EORTC QLQC30), and muscle strength were assessed. Testing occurred at baseline and after 12 weeks.Results: Training was feasible in 9 out of 10 participants and no serious adverse events occurred. It had beneficial effects on muscle strength (maximum voluntary isometric contraction of the quadriceps: RT +11 ± 9 Nm, CON −13 ± 25 Nm, p = 0.005), but not on fatigue (general fatigue score RT +0.3 ± 4.1, CON -1.5 ± 3.0, p = 0.223) or QoL (global QoL score RT −5.6 ± 16.1, CON −2.0 ± 18.2, p = 0.617).Conclusions: Progressive machine-based resistance training appears feasible in the majority of advanced cancer patients undergoing TKI therapy. However, its positive effects on muscle strength do not seem to be associated with positive effects on fatigue or quality of life. Future studies should therefore compare whether home-based training is more beneficial for patient-reported outcomes.Trial registration NCT01645150 
700 1 |a Wiskemann, Joachim  |e VerfasserIn  |0 (DE-588)141982187  |0 (DE-627)632856009  |0 (DE-576)327193654  |4 aut 
700 1 |a Vallet, Sonia  |d 1976-  |e VerfasserIn  |0 (DE-588)105867207X  |0 (DE-627)797396403  |0 (DE-576)414826493  |4 aut 
700 1 |a Haag, Georg Martin  |d 1979-  |e VerfasserIn  |0 (DE-588)133390934  |0 (DE-627)544043863  |0 (DE-576)29981548X  |4 aut 
700 1 |a Schembri, Emanuel  |e VerfasserIn  |0 (DE-588)1156350859  |0 (DE-627)1019135131  |0 (DE-576)502128836  |4 aut 
700 1 |a Jäger, Dirk  |d 1964-  |e VerfasserIn  |0 (DE-588)1032507535  |0 (DE-627)738505323  |0 (DE-576)380074125  |4 aut 
700 1 |a Grüllich, Carsten  |d 1965-  |e VerfasserIn  |0 (DE-588)14101914X  |0 (DE-627)624500985  |0 (DE-576)321797981  |4 aut 
773 0 8 |i Enthalten in  |t Supportive care in cancer  |d Berlin : Springer, 1993  |g 25(2017), 12, Seite 3655-3664  |h Online-Ressource  |w (DE-627)254909574  |w (DE-600)1463166-0  |w (DE-576)074754076  |x 1433-7339  |7 nnas  |a Resistance training as supportive measure in advanced cancer patients undergoing TKI therapy a controlled feasibility trial 
773 1 8 |g volume:25  |g year:2017  |g number:12  |g pages:3655-3664  |g extent:10  |a Resistance training as supportive measure in advanced cancer patients undergoing TKI therapy a controlled feasibility trial 
856 4 0 |u http://dx.doi.org/10.1007/s00520-017-3788-3  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s00520-017-3788-3  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180418 
993 |a Article 
994 |a 2017 
998 |g 14101914X  |a Grüllich, Carsten  |m 14101914X:Grüllich, Carsten  |d 910000  |e 910000PG14101914X  |k 0/910000/  |p 7  |y j 
998 |g 1032507535  |a Jäger, Dirk  |m 1032507535:Jäger, Dirk  |d 910000  |e 910000PJ1032507535  |k 0/910000/  |p 6 
998 |g 1156350859  |a Schembri, Emanuel  |m 1156350859:Schembri, Emanuel  |d 910000  |e 910000PS1156350859  |k 0/910000/  |p 5 
998 |g 133390934  |a Haag, Georg Martin  |m 133390934:Haag, Georg Martin  |d 910000  |e 910000PH133390934  |k 0/910000/  |p 4 
998 |g 105867207X  |a Vallet, Sonia  |m 105867207X:Vallet, Sonia  |d 910000  |e 910000PV105867207X  |k 0/910000/  |p 3 
998 |g 141982187  |a Wiskemann, Joachim  |m 141982187:Wiskemann, Joachim  |d 910000  |d 910100  |e 910000PW141982187  |e 910100PW141982187  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 137399057  |a Rosenberger, Friederike  |m 137399057:Rosenberger, Friederike  |d 910000  |d 910100  |e 910000PR137399057  |e 910100PR137399057  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1572128313  |e 3006372557 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["F. Rosenberger, J. Wiskemann, S. Vallet, G. M. Haag, E. Schembri, D. Jäger, C. Grüllich"]},"person":[{"family":"Rosenberger","given":"Friederike","role":"aut","display":"Rosenberger, Friederike"},{"display":"Wiskemann, Joachim","role":"aut","given":"Joachim","family":"Wiskemann"},{"family":"Vallet","role":"aut","given":"Sonia","display":"Vallet, Sonia"},{"display":"Haag, Georg Martin","role":"aut","given":"Georg Martin","family":"Haag"},{"family":"Schembri","given":"Emanuel","role":"aut","display":"Schembri, Emanuel"},{"family":"Jäger","display":"Jäger, Dirk","role":"aut","given":"Dirk"},{"display":"Grüllich, Carsten","role":"aut","given":"Carsten","family":"Grüllich"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"December 2017","dateIssuedKey":"2017"}],"recId":"1572128313","note":["Gesehen am 18.04.2018"],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"254909574","origin":[{"publisherPlace":"Berlin ; Heidelberg ; New York,NY","dateIssuedKey":"1993","publisher":"Springer","dateIssuedDisp":"1993-"}],"note":["Gesehen am 06.12.05"],"id":{"eki":["254909574"],"issn":["1433-7339"],"zdb":["1463166-0"]},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Resistance training as supportive measure in advanced cancer patients undergoing TKI therapy a controlled feasibility trialSupportive care in cancer","pubHistory":["1.1993 -"],"language":["eng"],"part":{"issue":"12","pages":"3655-3664","extent":"10","year":"2017","text":"25(2017), 12, Seite 3655-3664","volume":"25"},"title":[{"title_sort":"Supportive care in cancer","title":"Supportive care in cancer","subtitle":"official journal of the Multinational Association of Supportive Care in Cancer"}]}],"id":{"doi":["10.1007/s00520-017-3788-3"],"eki":["1572128313"]},"physDesc":[{"extent":"10 S."}],"language":["eng"],"title":[{"title_sort":"Resistance training as supportive measure in advanced cancer patients undergoing TKI therapy","title":"Resistance training as supportive measure in advanced cancer patients undergoing TKI therapy","subtitle":"a controlled feasibility trial"}]} 
SRT |a ROSENBERGERESISTANCE2017